Exosomes in colorectal carcinoma formation: ALIX under the magnifying glass

Modern Pathology

Volumn 29, Issue 8, 2016, Pages 928-938

  Valcz, Gïlbor ^a   Galamb, Orsolya ^a   Krenïcs, Tibor ^a   Spisïk, Sïndor ^b   Kalmïr, Alexandra ^c   Patai, Irpïd V ^c   Wichmann, Barna ^a   Dede, Kristóf ^d   Tulassay, Zsolt ^a,c   Molnïlr, Béla ^a,c  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c UZSOKI HOSPITAL   (Hungary)

^d SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ALG 2 INTERACTING PROTEIN X; ALPHA ENOLASE; ALPHA SMOOTH MUSCLE ACTIN; HEAT SHOCK PROTEIN 90 ALPHA; LIPOCORTIN 5; MESSENGER RNA; MOESIN; PHOSPHOGLYCERATE KINASE; PHOSPHOGLYCERATE KINASE 1; PROGRAMMED CELL DEATH 6 INTERACTING PROTEIN; PROTEIN; PROTEIN X; PYRUVATE KINASE; UNCLASSIFIED DRUG; CALCIUM BINDING PROTEIN; CELL CYCLE PROTEIN; ESCRT PROTEIN; PDCD6IP PROTEIN, HUMAN; TUMOR MARKER;

AGED; ARTICLE; CANCER STEM CELL; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; EXOSOME; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIVESICULAR BODY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECTUM BIOPSY; STROMA CELL; TISSUE MICROARRAY; TUMOR MICROENVIRONMENT; UPREGULATION; ADENOMA; CARCINOMA; CASE CONTROL STUDY; CHEMISTRY; COLORECTAL TUMOR; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENETICS; MIDDLE AGED; PATHOLOGY; PROCEDURES; VERY ELDERLY;

ADENOMA; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CALCIUM-BINDING PROTEINS; CARCINOMA; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; COLORECTAL NEOPLASMS; ENDOSOMAL SORTING COMPLEXES REQUIRED FOR TRANSPORT; EXOSOMES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIVESICULAR BODIES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR MICROENVIRONMENT;

EID: 84965011002     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2016.72     Document Type: Article

References (65)

1. Yang C, Robbins PD. The roles of tumor-derived exosomes in cancer pathogenesis. Clin Dev Immunol 2011; 2011: 842849.
2. Braicu C, Tomuleasa C, Monroig P, et al. Exosomes as divine messengers: are they the Hermes of modern molecular oncology?. Cell Death Differ 2015; 22: 34-45.
3. Baietti MF, Zhang Z, Mortier E, et al. Syndecansyntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol 2012; 14: 677-685.
4. Fevrier B, Raposo G. Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol 2004; 16: 415-421.
5. Hurley JH, Hanson PI. Membrane budding and scission by the ESCRT machinery: it's all in the neck. Nat Rev Mol Cell Biol 2010; 11: 556-566.
6. Roma-Rodrigues C, Fernandes AR, Baptista PV. Exosome in tumour microenvironment: overview of the crosstalk between normal and cancer cells. Biomed Res Int 2014; 2014: 179486.
7. Ragusa M, Statello L, Maugeri M, et al. Highly skewed distribution of miRNAs and proteins between colorectal cancer cells and their exosomes following Cetuximab treatment: biomolecular, genetic and translational implications. Oncoscience 2014; 1: 132-157.
8. Wang X, Ding X, Nan L, et al. Investigation of the roles of exosomes in colorectal cancer liver metastasis. Oncol Rep 2015; 33: 2445-2453.
9. Ji H, Greening DW, Barnes TW, et al. Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components. Proteomics 2013; 13: 1672-1686.
10. Fan X, Ouyang N, Teng H, et al. Isolation and characterization of spheroid cells from the HT29 colon cancer cell line. Int J Colorectal Dis 2011; 26: 1279-1285.
11. Feng HL, Liu YQ, Yang LJ, et al. Expression of CD133 correlates with differentiation of human colon cancer cells. Cancer Biol Ther 2010; 9: 216-223.
12. Kai K, Nagano O, Sugihara E, et al. Maintenance of HCT116 colon cancer cell line conforms to a stochastic model but not a cancer stem cell model. Cancer Sci 2009; 100: 2275-2282.
13. Lugli A, Iezzi G, Hostettler I, et al. Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer. Br J Cancer 2010; 103: 382-390.
14. Vaiopoulos AG, Kostakis ID, Koutsilieris M, et al. Colorectal cancer stem cells. Stem cells 2012; 30: 363-371.
15. Kahlert C, Kalluri R. Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med 2013; 91: 431-437.
16. Gangoda L, Boukouris S, Liem M, et al. Extracellular vesicles including exosomes are mediators of signal transduction: are they protective or pathogenic?. Proteomics 2015; 15: 260-271.
17. Grange C, Tapparo M, Collino F, et al. Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res 2011; 71: 5346-5356.
18. Valcz G, Sipos F, Tulassay Z, et al. Importance of carcinoma-Associated fibroblast-derived proteins in clinical oncology. J Clin Pathol 2014; 67: 1026-1031.
19. Räsänen K, Vaheri A. Activation of fibroblasts in cancer stroma. Exp Cell Res 2010; 316: 2713-2722.
20. Powell DW, Mifflin RC, Valentich JD, et al. Myofibroblasts. II. Intestinal subepithelial myofibroblasts. Am J Physiol 1999; 27: 183-201.
21. Silva J, Garcia V, Rodriguez M, et al. Analysis of exosome release and its prognostic value in human colorectal cancer. Genes Chromosomes Cancer 2012; 51: 409-418.
22. Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 2008; 110: 13-21.
23. Rabinowits G, Gercel-Taylor C, Day JM, et al. Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer 2009; 10: 42-46.
24. Jakobsen KR, Paulsen BS, Baek R, et al. Exosomal proteins as potential diagnostic markers in advanced non-small cell lung carcinoma. J Extracell Vesicles 2015; 4: 26659.
25. Hurley JH, Odorizzi G. Get on the exosome bus with ALIX. Nat Cell Biol 2012; 14: 654-655.
26. Bissig C, Gruenberg J. ALIX and the multivesicular endosome: ALIX in Wonderland. Trends Cell Biol 2014; 24: 19-25.
27. Yi X, Bouley R, Lin HY, et al. Alix (AIP1) is a vasopressin receptor (V2R)-interacting protein that increases lysosomal degradation of the V2R. Am J Physiol Renal Physiol 2007; 292: 1303-1313.
28. Tauro BJ, Greening DW, Mathias RA, et al. Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods 2012; 56: 293-304.
29. Johnson IR, Parkinson-Lawrence EJ, Keegan H, et al. Endosomal gene expression: a new indicator for prostate cancer patient prognosis?. Oncotarget 2015; 6: 37919-37929.
30. Duijvesz D, Burnum-Johnson KE, Gritsenko MA, et al. Proteomic profiling of exosomes leads to the identification of novel biomarkers for prostate cancer. PloS One 2013; 8: e82589.
31. Husi H, Skipworth RJ, Cronshaw A, et al. Programmed cell death 6 interacting protein (PDCD6IP) and Rabenosyn-5 (ZFYVE20) are potential urinary biomarkers for upper gastrointestinal cancer. Proteomics Clin Appl 2015; 9: 586-596.
32. Bosman FT, Carneiro F, Hruban RH, Theise ND, WHO classification of tumours of the digestive system. International Agency for Research on Cancer, 4th edn 2010.
33. Galamb O, Wichmann B, Sipos F, et al. Dysplasiacarcinoma transition specific transcripts in colonic biopsy samples. PloS One 2012; 7: e48547.
34. Galamb O, Sipos F, Solymosi N, et al. Diagnostic mRNA expression patterns of inflamed, benign, and malignant colorectal biopsy specimen and their correlation with peripheral blood results. Cancer Epidemiol Biomarkers Prev 2008; 17: 2835-2845.
35. Galamb O, Gyorffy B, Sipos F, et al. Inflammation, adenoma and cancer: objective classification of colon biopsy specimens with gene expression signature. Dis Markers 2008; 25: 1-16.
36. Matsuyama T, Ishikawa T, Mogushi K, et al. MUC12 mRNA expression is an independent marker of prognosis in stage II and stage III colorectal cancer. Int J Cancer 2010; 127: 2292-2299.
37. Hong Y, Ho KS, Eu KW, et al. A susceptibility gene set for early onset colorectal cancer that integrates diverse signaling pathways: implication for tumorigenesis. Clin Cancer Res 2007; 13: 1107-1114.
38. Hong Y, Downey T, Eu KW, et al. A 'metastasis-prone' signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics. Clin Exp Metastasis 2010; 27: 83-90.
39. Sabates-Bellver J, Van der Flier LG, de Palo M, et al. Transcriptome profile of human colorectal adenomas. Mol Cancer Res 2007; 5: 1263-1275.
40. Fleming M, Ravula S, Tatishchev SF, et al. Colorectal carcinoma: pathologic aspects. J Gastrointest Oncol 2012; 3: 153-173.
41. Valcz G, Krenacs T, Sipos F, et al. Lymphoid aggregates may contribute to the migration and epithelial commitment of bone marrow-derived cells in colonic mucosa. J Clin Pathol 2011; 64: 771-775.
42. Millard M, Pathania D, Shabaik Y, et al. Preclinical evaluation of novel triphenylphosphonium salts with broad-spectrum activity. PloS One 2010; 5: e13131.
43. Conover WJ. Practical Nonparametric Statistics, 3rd edn. John Wiley & Sons: New York, USA, 1999.
44. Team RC. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing: Vienna, Austria, 2015. Available at: http: //www.R-project.org/.
45. Nishimura S, Wakabayashi N, Toyoda K, et al. Expression of Musashi-1 in human normal colon crypt cells: a possible stem cell marker of human colon epithelium. Dig Dis Sci 2003; 48: 1523-1529.
46. Liotta LA, Kohn EC. The microenvironment of the tumour-host interface. Nature 2001; 411: 375-379.
47. Mueller MM, Fusenig NE. Friends or foes-bipolar effects of the tumour stroma in cancer. Nat Rev 2004; 4: 839-849.
48. Bosman FT, de Bruine A, Flohil C, et al. Epithelialstromal interactions in colon cancer. Int J Dev Biol 1993; 37: 203-211.
49. Valcz G, Patai AV, Kalmar A, et al. Myofibroblastderived SFRP1 as potential inhibitor of colorectal carcinoma field effect. PloS One 2014; 9: e106143.
50. Hong BS, Cho JH, Kim H, et al. Colorectal cancer cellderived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells. BMC Genomics 2009; 10: 556.
51. Diehl HC, Stuhler K, Klein-Scory S, et al. A catalogue of proteins released by colorectal cancer cells in vitro as an alternative source for biomarker discovery. Proteomics Clin Appl 2007; 1: 47-61.
52. Paggetti J, Haderk F, Seiffert M, et al. Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-Associated fibroblasts. Blood 2015; 126: 1106-1117.
53. Bhattacharya S, Pal K, Sharma AK, et al. GAIP interacting protein C-Terminus regulates autophagy and exosome biogenesis of pancreatic cancer through metabolic pathways. PloS One 2014; 9: e114409.
54. Hitchins MP, Lin VA, Buckle A, et al. Epigenetic inactivation of a cluster of genes flanking MLH1 in microsatellite-unstable colorectal cancer. Cancer Res 2007; 67: 9107-9116.
55. Razi M, Futter CE. Distinct roles for Tsg101 and Hrs in multivesicular body formation and inward vesiculation. Mol Biol Cell 2006; 17: 3469-3483.
56. Bache KG, Brech A, Mehlum A, et al. Hrs regulates multivesicular body formation via ESCRT recruitment to endosomes. J Cell Biol 2003; 162: 435-442.
57. Odorizzi G. The multiple personalities of Alix. J Cell Sci 2006; 119: 3025-3032.
58. Suetsugu A, Honma K, Saji S, et al. Imaging exosome transfer from breast cancer cells to stroma at metastatic sites in orthotopic nude-mouse models. Adv Drug Deliv Rev 2013; 65: 383-390.
59. Shaw PJ, Rawlins DJ. The point-spread function of a confocal microscope: its measurement and use in deconvolution of 3-D data. J Microsc 1991; 163: 151-165.
60. Kumar D, Gupta D, Shankar S, et al. Biomolecular characterization of exosomes released from cancer stem cells: possible implications for biomarker and treatment of cancer. Oncotarget 2015; 6: 3280-3291.
61. Azmi AS, Bao B, Sarkar FH. Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev 2013; 32: 623-642.
62. Brinton LT, Sloane HS, Kester M, et al. Formation and role of exosomes in cancer. Cell Mol Life Sci 2015; 72: 659-671.
63. Corcoran C, Rani S, O'Brien K, et al. Docetaxelresistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes. PloS One 2012; 7: e50999.
64. Hu Y, Yan C, Mu L, et al. Fibroblast-derived exosomes contribute to chemoresistance through priming cancer stem cells in colorectal cancer. PloS One 2015; 10: e0125625.
65. Lee TH, Chennakrishnaiah S, Audemard E, et al. Oncogenic ras-driven cancer cell vesiculation leads to emission of double-stranded DNA capable of interacting with target cells. Biochem Biophys Res Commun 2014; 451: 295-301.